Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melperone in Psychosis Associated With Parkinson's Disease
NCT00125138Phase 2Completed
- Sponsor
- Lundbeck
- Start
- Jul 2005
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of melperone in psychosis (4 arms), sponsored by Lundbeck. Primary endpoint: Patient Evaluation of Symptoms of Psychosis at 6 weeks. Started Jul 2005; status: completed.
02
Drugs
melperone
03
Conditions
psychosis
Beyond the preview
Go deeper on NCT00125138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00125138.